ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
-0,15%
Euro vs US Dollar
1,07175
0,00%
Bitcoin
66.270,38
0,12%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Inari Medical Inc (NARI)

  7. Inari Medical Inc (NARI) News

NARI

Inari Medical (NARI)

Inari Medical Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NARI
DatumZeitQuelleÜberschriftSymbolFirma
14/06/202422h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NARIInari Medical Inc
12/06/202422h21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NARIInari Medical Inc
10/06/202411h45PR Newswire (US)Inari Medical, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before July 12, 2024 to Discuss Your Rights - NARINASDAQ:NARIInari Medical Inc
05/06/202411h45PR Newswire (US)The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Inari Medical, Inc.(NARI) ShareholdersNASDAQ:NARIInari Medical Inc
31/05/202423h01Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:NARIInari Medical Inc
31/05/202422h14Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:NARIInari Medical Inc
31/05/202401h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NARIInari Medical Inc
29/05/202411h45PR Newswire (US)Shareholders that lost money on Inari Medical, Inc.(NARI) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:NARIInari Medical Inc
28/05/202422h28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NARIInari Medical Inc
23/05/202414h00GlobeNewswire Inc.Inari Medical Files Patent Infringement Lawsuit Against Imperative Care and Truvic MedicalNASDAQ:NARIInari Medical Inc
22/05/202400h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NARIInari Medical Inc
21/05/202411h45PR Newswire (US)July 12, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NARINASDAQ:NARIInari Medical Inc
20/05/202422h25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NARIInari Medical Inc
15/05/202422h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NARIInari Medical Inc
14/05/202400h16Business WireGrant & Eisenhofer Files Class Action Lawsuit Against Inari Medical, Inc. on Behalf of Institutional InvestorNASDAQ:NARIInari Medical Inc
06/05/202413h00GlobeNewswire Inc.Inari Medical to Participate in the 2024 Bank of America Securities Healthcare ConferenceNASDAQ:NARIInari Medical Inc
30/04/202422h05GlobeNewswire Inc.Inari Medical Reports First Quarter 2024 Financial ResultsNASDAQ:NARIInari Medical Inc
17/04/202422h05GlobeNewswire Inc.Inari Medical to Announce First Quarter 2024 Financial ResultsNASDAQ:NARIInari Medical Inc
11/04/202422h05GlobeNewswire Inc.Inari Medical Announces the Release of 2023 Ethos and Sustainability ReportNASDAQ:NARIInari Medical Inc
02/04/202422h05GlobeNewswire Inc.Inari Medical Strengthens Senior Leadership Team with Addition of Two ExecutivesNASDAQ:NARIInari Medical Inc
25/03/202423h15PR Newswire (US)AppFolio Set to Join S&P MidCap 400; Inari Medical to Join S&P SmallCap 600NASDAQ:NARIInari Medical Inc
12/03/202421h05GlobeNewswire Inc.Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT RegistryNASDAQ:NARIInari Medical Inc
28/02/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NARIInari Medical Inc
28/02/202422h05GlobeNewswire Inc.Inari Medical Reports Fourth Quarter 2023 Financial ResultsNASDAQ:NARIInari Medical Inc
23/02/202422h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NARIInari Medical Inc
22/02/202403h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NARIInari Medical Inc
22/02/202403h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NARIInari Medical Inc
22/02/202403h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NARIInari Medical Inc
14/02/202422h05GlobeNewswire Inc.Inari Medical to Announce Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:NARIInari Medical Inc
14/02/202412h29Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NARIInari Medical Inc
 Showing the most relevant articles for your search:NASDAQ:NARI

Kürzlich von Ihnen besucht

AMEX
XLE
Energy Select Sector SPDR
TG
RHM
Rheinmetall
COIN
BTCUSD
Bitcoin
NYSE
MRK
Merck
NASDAQ
GOOGL
Alphabet
CCOM
SILVER
SILVER
NYSE
JPM
JP Morgan Chase
COIN
SOLUSD
Solana
TG
MBG
MercedesBenz
TG
432
Arbor Metals
DBI
SDXP
SDAX
NASDAQ
TSLA
Tesla
USOTC
ADDYY
Adidas (QX)
TG
BAYN
Bayer
NASDAQ
AMZN
Amazon.com
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten